These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32014008)

  • 1. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma.
    Xu F; Liu Z; Liu R; Lu C; Wang L; Mao W; Zhu Q; Shou H; Zhang K; Li Y; Chu Y; Gu J; Ge D
    Cell Commun Signal; 2020 Feb; 18(1):17. PubMed ID: 32014008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2.
    Zhang Z; Liang X; Ren L; Zhang S; Li S; Wan T; Xu D; Lv S
    Thorac Cancer; 2020 Aug; 11(8):2306-2315. PubMed ID: 32633082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 8. Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
    Yao Q; Yang J; Liu T; Zhang J; Zheng Y
    FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
    Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
    Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
    Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
    Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas.
    Zhang H; Qin G; Zhang C; Yang H; Liu J; Hu H; Wu P; Liu S; Yang L; Chen X; Zhao X; Wang L; Zhang Y
    J Exp Clin Cancer Res; 2021 Jun; 40(1):209. PubMed ID: 34167551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma.
    Deng L; Zhang X; Xiang X; Xiong R; Xiao D; Chen Z; Liu K; Feng G
    Technol Cancer Res Treat; 2021; 20():15330338211038492. PubMed ID: 34520294
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression.
    Zu Y; Ping W; Deng T; Zhang N; Fu X; Sun W
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27061118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
    Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
    Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.